Submit your email to push it up the queue
Molecular Devices Shanghai Limited, a prominent player in the life sciences industry, is headquartered in China (CN) and operates extensively across Asia. Founded in 1996, the company has established itself as a leader in the development of innovative analytical instruments and software for drug discovery and biological research. Specialising in high-performance microplate readers, imaging systems, and automation solutions, Molecular Devices stands out for its commitment to precision and reliability. The company’s core products are designed to enhance laboratory efficiency and data accuracy, catering to a diverse clientele in pharmaceuticals, biotechnology, and academic research. With a strong market position, Molecular Devices has achieved significant milestones, including numerous awards for its cutting-edge technology and contributions to scientific advancement. Its dedication to quality and innovation continues to drive its success in the competitive life sciences sector.
How does Molecular Devices Shanghai Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Molecular Devices Shanghai Limited's score of 59 is higher than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Molecular Devices Shanghai Limited, headquartered in China (CN), currently does not report specific carbon emissions data, as no emissions figures are available. The company is a current subsidiary of Danaher Corporation, which influences its climate commitments and initiatives. Molecular Devices Shanghai Limited inherits its climate targets and performance metrics from Danaher Corporation, which has established various sustainability initiatives. These include commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Molecular Devices Shanghai Limited are not detailed. As part of Danaher Corporation's broader sustainability strategy, the company is likely aligned with industry-standard climate terminology and practices, focusing on reducing emissions across its operations. The absence of direct emissions data suggests that the company may still be in the process of developing its own specific climate commitments or reporting frameworks. In summary, while Molecular Devices Shanghai Limited does not currently provide emissions data or specific reduction targets, it is positioned within a corporate structure that prioritises sustainability through the initiatives of its parent company, Danaher Corporation.
Access structured emissions data, company-specific emission factors, and source documents
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|
Scope 1 | 138,341,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 219,166,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
Scope 3 | - | - | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Molecular Devices Shanghai Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.